サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1585104

がん温熱療法の世界市場：業界分析、規模、シェア、成長、動向、予測（2024年～2031年）

Hyperthermia Treatment for Cancer Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

出版日
ページ情報
英文 121 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
がん温熱療法の世界市場：業界分析、規模、シェア、成長、動向、予測（2024年～2031年）
出版日: 2024年11月06日
発行: Persistence Market Research
ページ情報: 英文 121 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界のがん温熱療法市場について調査し、機器タイプ別、エンドユーザー別、用途別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場イントロダクション

第3章 世界のがん温熱療法市場分析シナリオ

  • 価格分析
  • 市場と予測

第4章 市場力学

  • マクロ経済要因
  • 促進要因
  • 抑制要因
  • 機会
  • 予測要因- 関連性と影響

第5章 世界のがん温熱療法市場の分析と予測：機器タイプ別

  • イントロダクション
  • ベーシスポイントシェア（BPS）分析：機器タイプ別
  • 前年比成長予測：機器タイプ別
  • 市場価値予測：機器タイプ別
  • 市場の魅力：機器タイプ別

第6章 世界のがん温熱療法市場の分析と予測：エンドユーザー別

  • イントロダクション
  • ベーシスポイントシェア（BPS）分析：エンドユーザー別
  • 前年比成長予測：エンドユーザー別
  • 市場価値予測：エンドユーザー別
  • 市場の魅力：エンドユーザー別

第7章 世界のがん温熱療法市場の分析と予測：用途別

  • イントロダクション
  • ベーシスポイントシェア（BPS）分析：用途別
  • 前年比成長予測：用途別
  • 市場価値予測：用途別
  • 市場の魅力：用途別

第8章 世界のがん温熱療法市場の分析と予測：地域別

  • ベーシスポイントシェア（BPS）分析：地域別
  • 前年比成長予測：地域別
  • 市場価値予測：地域別
  • 市場の魅力：地域別

第9章 北米のがん温熱療法市場の分析と予測

第10章 欧州のがん温熱療法市場の分析と予測

第11章 ラテンアメリカのがん温熱療法市場の分析と予測

第12章 アジア太平洋のがん温熱療法市場の分析と予測

第13章 中東・アフリカのがん温熱療法市場の分析と予測

第14章 競合情勢

  • 競合ダッシュボード
  • 企業プロファイル（詳細- 概要、財務、戦略、最近の動向）
    • Celsius42+GmbH
    • Pyrexar Medical Inc.
    • Oncothermia
    • Hydrosun GmbH
    • Yamamoto Vinita Co., Ltd
    • Andromedic Srl
    • Haifu Medical Technology Co. Ltd

第15章 使用される前提条件と頭字語

第16章 調査手法

目次
Product Code: PMRREP14632

Persistence Market Research has recently released a comprehensive report on the global Hyperthermia Treatment for Cancer Market, providing an in-depth analysis of key market dynamics, including driving factors, emerging trends, opportunities, and challenges. This report delivers a detailed understanding of the market landscape, offering valuable insights to help stakeholders make informed decisions.

Key Insights:

  • Hyperthermia Treatment Market Size (2024E): USD 166.7 Mn
  • Projected Market Value (2031F): USD 249.1 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031): 5.9%

Hyperthermia Treatment for Cancer Market - Report Scope:

The Hyperthermia Treatment for Cancer market involves treatments that use high temperatures to target cancer cells, either alone or in combination with other therapies like chemotherapy and radiation. Techniques include local, regional, and whole-body hyperthermia, with applications across various cancer types. The market is driven by an increasing incidence of cancer globally, growing demand for minimally invasive treatments, and advancements in hyperthermia technologies. Hyperthermia is known to enhance the effects of radiation and chemotherapy, providing a promising complementary treatment option for cancer patients.

Market Growth Drivers:

Several factors are driving the growth of the global Hyperthermia Treatment for Cancer market, including the rising cancer prevalence worldwide, technological advancements in hyperthermia systems, and increasing awareness of its benefits as an adjunctive treatment. An increased focus on personalized cancer therapies and the shift towards non-invasive treatment options further propel market expansion. Growing healthcare investments and supportive government policies in oncology treatment are also facilitating market growth.

Market Restraints:

The Hyperthermia Treatment for Cancer market faces challenges, such as high equipment costs, limited availability of specialized treatment centers, and a need for trained professionals. The lack of standardized treatment protocols and potential side effects associated with hyperthermia therapy, including skin irritation and burns, may impact adoption. Additionally, limited awareness of hyperthermia treatment options in some regions and restricted insurance coverage pose challenges to market growth. Addressing these issues involves increasing access to equipment and improving awareness among healthcare providers and patients.

Market Opportunities:

Significant opportunities exist in the Hyperthermia Treatment for Cancer market as new technological developments make treatments more accessible and effective. Advancements in precision hyperthermia techniques, such as microwave and ultrasound hyperthermia, are opening new avenues for treatment. Collaboration between healthcare providers and equipment manufacturers, along with partnerships for clinical trials and research, is expected to drive innovation and expand treatment adoption. Increasing demand in emerging economies, driven by rising healthcare infrastructure and investment, also presents substantial growth opportunities.

Key Questions Answered in the Report:

  • What are the primary factors driving growth in the global Hyperthermia Treatment for Cancer market?
  • Which hyperthermia treatment techniques are seeing the highest demand across different cancer types?
  • How are technological advancements in hyperthermia systems impacting the competitive landscape?
  • Who are the major players in the Hyperthermia Treatment for Cancer market, and what strategies are they implementing to stay competitive?
  • What are the emerging trends and future prospects for the global Hyperthermia Treatment for Cancer market?

Competitive Intelligence and Business Strategy:

Leading companies in the global Hyperthermia Treatment for Cancer market, such as Pyrexar Medical Inc., Celsius42 GmbH, and ThermoChem Inc., are focusing on technological advancements, product differentiation, and strategic partnerships to strengthen their market positions. These companies invest heavily in research and development to enhance treatment precision, efficiency, and safety. Collaborations with oncology centers, clinical trials, and distribution partnerships are crucial for expanding market reach. Emphasizing patient-centered care, cost-effectiveness, and technological innovations are key strategies to maintain a competitive edge in this specialized market.

Key Companies Profiled:

  • Pyrexar Medical Inc.
  • Celsius42 GmbH
  • ThermoChem Inc.
  • Andromedic Srl
  • SIRIO Medical Devices
  • Oncotherm Ltd.
  • BSD Medical Corporation
  • Yamamoto Vinita Co., Ltd.
  • Perseon Corporation

Hyperthermia Treatment for Cancer Industry Research by Category:

By Device Type

  • Microwave Hyperthermia Device
  • Ultrasound Hyperthermia Device
  • Infrared Hyperthermia Device
  • Short-wave Hyperthermia Device

By End User

  • Hospitals
  • Clinics
  • Research Institutes
  • Cancer Centers
  • Others

By Application

  • Breast Cancer
  • Liver Cancer
  • Soft Tissue Sarcoma
  • Leukemia
  • Head and Neck Tumors
  • Prostate Cancer
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa

Table of Contents

1. Executive Summary

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy

3. Global Hyperthermia Treatment for Cancer Market Analysis Scenario

  • 3.1. Pricing Analysis
    • 3.1.1. Pricing Assumptions
    • 3.1.2. Price Projections Per Region
  • 3.2. Market Size (US$ Mn) and Forecast
    • 3.2.1. Market Size and Y-o-Y Growth
    • 3.2.2. Absolute $ Opportunity

4. Market Dynamics

  • 4.1. Macro-economic Factors
  • 4.2. Drivers
    • 4.2.1. Supply Side
    • 4.2.2. Demand Side
  • 4.3. Restraints
  • 4.4. Opportunity
  • 4.5. Forecast Factors - Relevance and Impact

5. Global Hyperthermia Treatment for Cancer Market Analysis and Forecasts, By Devices Type

  • 5.1. Introduction
  • 5.2. Basis Point Share (BPS) Analysis By Devices Type
  • 5.3. Y-o-Y Growth Projections By Devices Type
  • 5.4. Market Value Forecast By Devices Type, 2024-2031
    • 5.4.1. Microwave Hyperthermia Device
    • 5.4.2. Ultrasound Hyperthermia Device
    • 5.4.3. Infrared Therapy Device
    • 5.4.4. Short-wave Therapy Device
  • 5.5. Market Attractiveness By Devices Type

6. Global Hyperthermia Treatment for Cancer Market Analysis and Forecasts, By End User

  • 6.1. Introduction
  • 6.2. Basis Point Share (BPS) Analysis By End User
  • 6.3. Y-o-Y Growth Projections By End User
  • 6.4. Market Value Forecast By End User, 2024-2031
    • 6.4.1. Hospitals
    • 6.4.2. Clinics
    • 6.4.3. Research Institutes
    • 6.4.4. Cancer Centers
    • 6.4.5. Others
  • 6.5. Market Attractiveness By End User

7. Global Hyperthermia Treatment for Cancer Market Analysis and Forecasts, By Application

  • 7.1. Introduction
  • 7.2. Basis Point Share (BPS) Analysis By Application
  • 7.3. Y-o-Y Growth Projections By Application
  • 7.4. Market Value Forecast By Application, 2024-2031
    • 7.4.1. Breast Cancer
    • 7.4.2. Liver cancer
    • 7.4.3. Soft Tissue sarcoma
    • 7.4.4. Leukemia
    • 7.4.5. Head and neck tumors
    • 7.4.6. Prostate Cancer
    • 7.4.7. Others
  • 7.5. Market Attractiveness By Application

8. Global Hyperthermia Treatment for Cancer Market Analysis and Forecasts, By Region

  • 8.1. Basis Point Share (BPS) Analysis By Region
  • 8.2. Y-o-Y Growth Projections By Region
  • 8.3. Market Value Forecast By Region
    • 8.3.1. North America
    • 8.3.2. Europe
    • 8.3.3. Latin America
    • 8.3.4. Asia Pacific
    • 8.3.5. Middle East & Africa
  • 8.4. Market Attractiveness By Region

9. North America Hyperthermia Treatment for Cancer Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Basis Point Share (BPS) Analysis By Country
    • 9.1.2. Y-o-Y Growth Projections By Country
    • 9.1.3. Key Regulations
  • 9.2. Market Value Forecast By Devices Type, 2024-2031
    • 9.2.1. Microwave Hyperthermia Device
    • 9.2.2. Ultrasound Hyperthermia Device
    • 9.2.3. Infrared Therapy Device
    • 9.2.4. Short-wave Therapy Device
  • 9.3. Market Value Forecast By End User, 2024-2031
    • 9.3.1. Hospitals
    • 9.3.2. Clinics
    • 9.3.3. Research Institutes
    • 9.3.4. Cancer Centers
    • 9.3.5. Others
  • 9.4. Market Value Forecast By Application, 2024-2031
    • 9.4.1. Breast Cancer
    • 9.4.2. Liver cancer
    • 9.4.3. Soft Tissue sarcoma
    • 9.4.4. Leukemia
    • 9.4.5. Head and neck tumors
    • 9.4.6. Prostate Cancer
    • 9.4.7. Others
  • 9.5. Market Value Forecast By Country, 2024-2031
    • 9.5.1. US
    • 9.5.2. Canada
  • 9.6. Market Attractiveness Analysis
    • 9.6.1. By Devices Type
    • 9.6.2. By End User
    • 9.6.3. By Application
    • 9.6.4. By Country
  • 9.7. Prominent Trends

10. Europe Hyperthermia Treatment for Cancer Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Basis Point Share (BPS) Analysis By Country
    • 10.1.2. Y-o-Y Growth Projections By Country
    • 10.1.3. Key Regulations
  • 10.2. Market Value Forecast By Devices Type, 2024-2031
    • 10.2.1. Microwave Hyperthermia Device
    • 10.2.2. Ultrasound Hyperthermia Device
    • 10.2.3. Infrared Therapy Device
    • 10.2.4. Short-wave Therapy Device
  • 10.3. Market Value Forecast By End User, 2024-2031
    • 10.3.1. Hospitals
    • 10.3.2. Clinics
    • 10.3.3. Research Institutes
    • 10.3.4. Cancer Centers
    • 10.3.5. Others
  • 10.4. Market Value Forecast By Application, 2024-2031
    • 10.4.1. Breast Cancer
    • 10.4.2. Liver cancer
    • 10.4.3. Soft Tissue sarcoma
    • 10.4.4. Leukemia
    • 10.4.5. Head and neck tumors
    • 10.4.6. Prostate Cancer
    • 10.4.7. Others
  • 10.5. Market Value Forecast By Country, 2024-2031
    • 10.5.1. Germany
    • 10.5.2. France
    • 10.5.3. Italy
    • 10.5.4. U.K.
    • 10.5.5. Spain
    • 10.5.6. Russia
    • 10.5.7. Rest of Europe
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Devices Type
    • 10.6.2. By End User
    • 10.6.3. By Application
    • 10.6.4. By Country
  • 10.7. Prominent Trends

11. Latin America Hyperthermia Treatment for Cancer Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Basis Point Share (BPS) Analysis By Country
    • 11.1.2. Y-o-Y Growth Projections By Country
  • 11.2. Market Value Forecast By Devices Type, 2024-2031
    • 11.2.1. Microwave Hyperthermia Device
    • 11.2.2. Ultrasound Hyperthermia Device
    • 11.2.3. Infrared Therapy Device
    • 11.2.4. Short-wave Therapy Device
  • 11.3. Market Value Forecast By End User, 2024-2031
    • 11.3.1. Hospitals
    • 11.3.2. Clinics
    • 11.3.3. Research Institutes
    • 11.3.4. Cancer Centers
    • 11.3.5. Others
  • 11.4. Market Value Forecast By Application, 2024-2031
    • 11.4.1. Breast Cancer
    • 11.4.2. Liver cancer
    • 11.4.3. Soft Tissue sarcoma
    • 11.4.4. Leukemia
    • 11.4.5. Head and neck tumors
    • 11.4.6. Prostate Cancer
    • 11.4.7. Others
  • 11.5. Market Value Forecast By Country, 2024-2031
    • 11.5.1. Brazil
    • 11.5.2. Mexico
    • 11.5.3. Rest of the Latin America
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Devices Type
    • 11.6.2. By End User
    • 11.6.3. By Application
    • 11.6.4. By Country
  • 11.7. Prominent Trends

12. Asia Pacific Hyperthermia Treatment for Cancer Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Basis Point Share (BPS) Analysis By Country
    • 12.1.2. Y-o-Y Growth Projections By Country
  • 12.2. Market Value Forecast By Devices Type, 2024-2031
    • 12.2.1. Microwave Hyperthermia Device
    • 12.2.2. Ultrasound Hyperthermia Device
    • 12.2.3. Infrared Therapy Device
    • 12.2.4. Short-wave Therapy Device
  • 12.3. Market Value Forecast By End User, 2024-2031
    • 12.3.1. Hospitals
    • 12.3.2. Clinics
    • 12.3.3. Research Institutes
    • 12.3.4. Cancer Centers
    • 12.3.5. Others
  • 12.4. Market Value Forecast By Application, 2024-2031
    • 12.4.1. Breast Cancer
    • 12.4.2. Liver cancer
    • 12.4.3. Soft Tissue sarcoma
    • 12.4.4. Leukemia
    • 12.4.5. Head and neck tumors
    • 12.4.6. Prostate Cancer
    • 12.4.7. Others
  • 12.5. Market Value Forecast By Country, 2024-2031
    • 12.5.1. Japan
    • 12.5.2. China
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Devices Type
    • 12.6.2. By End User
    • 12.6.3. By Application
    • 12.6.4. By Country
  • 12.7. Prominent Trends

13. Middle East & Africa Hyperthermia Treatment for Cancer Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Basis Point Share (BPS) Analysis By Country
    • 13.1.2. Y-o-Y Growth Projections By Country
  • 13.2. Market Value Forecast By Devices Type, 2024-2031
    • 13.2.1. Microwave Hyperthermia Device
    • 13.2.2. Ultrasound Hyperthermia Device
    • 13.2.3. Infrared Therapy Device
    • 13.2.4. Short-wave Therapy Device
  • 13.3. Market Value Forecast By End User, 2024-2031
    • 13.3.1. Hospitals
    • 13.3.2. Clinics
    • 13.3.3. Research Institutes
    • 13.3.4. Cancer Centers
    • 13.3.5. Others
  • 13.4. Market Value Forecast By Application, 2024-2031
    • 13.4.1. Breast Cancer
    • 13.4.2. Liver cancer
    • 13.4.3. Soft Tissue sarcoma
    • 13.4.4. Leukemia
    • 13.4.5. Head and neck tumors
    • 13.4.6. Prostate Cancer
    • 13.4.7. Others
  • 13.5. Market Value Forecast By Country, 2024-2031
    • 13.5.1. South Africa
    • 13.5.2. GCC Countries
    • 13.5.3. Rest of MEA
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Devices Type
    • 13.6.2. By End User
    • 13.6.3. By Application
    • 13.6.4. By Country
  • 13.7. Prominent Trends

14. Competition Landscape

  • 14.1. Competition Dashboard
  • 14.2. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 14.2.1. Celsius42+ GmbH
    • 14.2.2. Pyrexar Medical Inc.
    • 14.2.3. Oncothermia
    • 14.2.4. Hydrosun GmbH
    • 14.2.5. Yamamoto Vinita Co., Ltd
    • 14.2.6. Andromedic Srl
    • 14.2.7. Haifu Medical Technology Co. Ltd

15. Assumptions and Acronyms Used

16. Research Methodology